4//SEC Filing
CORE LABORATORIES N V 4
Accession 0001000229-16-000153
CIK 0001000229operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:16 PM ET
Size
6.0 KB
Accession
0001000229-16-000153
Insider Transaction Report
Form 4
DEMSHUR DAVID M
DirectorChief Executive Officer
Transactions
- Award
Restricted Performance Shares
2016-02-16+52,995→ 52,995 totalExercise: $0.00→ Common Shares (52,995 underlying)
Footnotes (1)
- [F1]Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, these awards would vest at the end of a three-year performance period that begins on January 1, 2016 and ends on December 31, 2018 (the "Performance Period"). 80% of the restricted performance shares will vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period. The remaining 20% of the restricted performance shares will vest only upon the Company's return on invested capital being the highest among the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period. For any criterion that is not met, then the respective shares applicable to that criterion shall not vest and shall be forfeited.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:16 PM ET
- Size
- 6.0 KB